Early Access to Medicines Scheme (EAMS) operational guidance alerts

The ADTC Collaborative works with pharmaceutical companies to develop operational guidance for medicines granted EAMS status. The guidance outlines operational issues for the EAMS medicine for health boards including:

• supply arrangements
• patient information
• pharmacovigilance requirements
• EAMS termination arrangements

---